Clinical Trial Update: Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression [NA]

View source ↗

Summary

A completed clinical trial (NCT00285727) evaluating ropinirole controlled-release as an adjunctive treatment for major depressive disorder has been reported. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ropinirole CR (ropinirole)

Snippet

Sponsor: Stanford University | Conditions: Depressive Disorder, Major | NA | Status: COMPLETED